Percutaneous Balloon Mitral Valvuloplasty: Echocardiographic Eligibility and Procedural Guidance.

Interv Cardiol Clin

Heart Valve Program, Corrigan Minehan Heart Center, Massachusetts General Hospital, Yawkey Building Suite 5B, 55 Fruit Street, Boston, MA 02114, USA.

Published: July 2018

Rheumatic mitral stenosis remains a common disease in the developing world. Percutaneous mitral balloon valvuloplasty is an important therapy for rheumatic mitral stenosis. Echocardiography plays a critical role in the diagnosis of rheumatic mitral stenosis and the assessment of suitability for and guidance of percutaneous mitral valvuloplasty.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iccl.2018.04.003DOI Listing

Publication Analysis

Top Keywords

rheumatic mitral
12
mitral stenosis
12
mitral valvuloplasty
8
percutaneous mitral
8
mitral
6
percutaneous balloon
4
balloon mitral
4
valvuloplasty echocardiographic
4
echocardiographic eligibility
4
eligibility procedural
4

Similar Publications

Introduction: The severity of mitral stenosis (MS) is commonly assessed using mitral valve area (MVA) measured with transthoracic echocardiography (TTE). The dimensionless index (DI) of mitral valve (MV) was recently studied in degenerative MS. We evaluated DI MV in rheumatic MS and studied its relationship with clinical outcomes.

View Article and Find Full Text PDF

Rheumatic heart disease remains prevalent in some regions of Australia and New Zealand. Echocardiography is the gold standard for detection and diagnosis using the 2023 World Heart Federation guidelines. The guidelines describe specific features of mitral and aortic valve morphology and define pathological regurgitation associated with RHD.

View Article and Find Full Text PDF

Mitral valve infective endocarditis as a manifestation of disseminated Cryptococcus neoformans infection: a case report.

Arch Peru Cardiol Cir Cardiovasc

December 2024

Departamento de Cardiología Clínica. Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, Ciudad De México, Mexico. Departamento de Cardiología Clínica Instituto Nacional de Cardiología Ignacio Chávez Ciudad De México Mexico.

Infective endocarditis is a disease that affects mainly the endocardial surface of the heart and cardiac valves (native or prosthetic). The main risk factors for developing infective endocarditis are male sex, older age, intracardiac shunts, prosthetic valves, rheumatic, and congenital heart disease, intracardiac devices, intravenous drugs use, immunosuppression, and hemodialysis. Streptococci and Staphylococci spp.

View Article and Find Full Text PDF

Background: In developing countries, rheumatic mitral valve stenosis (MS) is still a problem and its progression leads to left atrial (LA) damage. Due to the complexity of the LA geometry, currently used techniques like antero-posterior dimension (LAD) and 2D echo derived LA volume (LAV) have several limitations that are corrected by 3D derived LA volumes in addition to functional evaluation.

Purpose: To assess the LA functions using 2D speckle tracking echocardiography and 3D transthoracic echocardiography in patients with clinically significant MS in comparison to normal healthy subjects.

View Article and Find Full Text PDF

Percutaneous Transvenous Mitral Commissurotomy for Patients with Rheumatic Heart Disease.

Int Heart J

January 2025

Department of Cardiac Surgery Center, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Capital Medical University.

Rheumatic heart disease remains common in developing countries. Current guidelines recommend percutaneous mitral commissurotomy (PTMC) as the preferred treatment for patients with rheumatic mitral stenosis (MS). This study reports the clinical outcomes of PTMC for rheumatic MS in contemporary Chinese patients and analyzes prognostic factors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!